Subscribe To
Longeveron to Report Third Quarter 2023 Results and Provide Corporate Update on November 10, 2023
MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, announced today that it will report its third quarter 2023 financial results prior to the market open on Friday November 10, 2023. The Company will host a […] The post Longeveron to Report Third Quarter 2023 Results and Provide Corporate Update on November 10, 2023 appea...
Read More
Posted: Nov 3 2023, 12:00
Author Name: forextv
Views: 112174